See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

The Dawn of Personalized DNA Vaccines

Summary by Inside Precision Medicine
Luigi Aurisicchio, PhD, is the CEO of Neomatrix Biotech, a company developing neoantigen cancer vaccines. Their platform brings together expertise in cancer biology and immuno-oncology with several advanced technologies. These include the identification of tumor-specific neoantigens, the design and production of fully synthetic, personalized DNA vaccines, and a delivery system that enhances the immune response and works synergistically with immu…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Inside Precision MedicineInside Precision Medicine

The Dawn of Personalized DNA Vaccines

Luigi Aurisicchio, PhD, is the CEO of Neomatrix Biotech, a company developing neoantigen cancer vaccines. Their platform brings together expertise in cancer biology and immuno-oncology with several advanced technologies. These include the identification of tumor-specific neoantigens, the design and production of fully synthetic, personalized DNA vaccines, and a delivery system that enhances the immune response and works synergistically with immu…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Inside Precision Medicine broke the news in on Friday, August 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal